Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07467720 · ClinicalTrials.gov registry record · NA

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

A NA study, sponsored by Baylor Research Institute.

Not yet
Registry status
NA
Development phase
75
Enrollment target

NCT07467720: Clinical Trial NA study, sponsored by Baylor Research Institute.

NCT07467720 is a NA study that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07467720, a NA study, has not yet begun recruiting, sponsored by Baylor Research Institute.

NOT YET RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

Primary Outcome

The difference in radiation exposure to the care team using a Raysafe i3 dosimeter badge. The two methods being compared are traditional lead aprons and shields and the RAMPART IC System (Guardian, Bunker, Shadow, and Sentry) with optional lead aprons in peripheral cases.

Interventions

  • DEVICE Rampart IC System

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2026-05-15
Est. Completion 2027-05-15
Phase NA
Baylor Research Institute

180 total trials

What is known before NCT07467720 opens enrollment

NCT07467720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Rampart IC System is the first listed.

NCT07467720 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07467720 about?

NCT07467720 is a clinical study titled "Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial". Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

What is the current status of trial NCT07467720?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-05-15. Estimated completion is 2027-05-15.

What interventions are being tested in trial NCT07467720?

The interventions under investigation include: Rampart IC System (DEVICE).

Who is sponsoring clinical trial NCT07467720?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07467720's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07467720, the US trial registry maintained by the National Library of Medicine. NCT07467720 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.